Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance

Cipta Sarana Medika Tbk.Trade
Saraswanti Indoland Development Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 2.87M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp108 (market cap 608.51B, 12.05M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is far larger — about 3.7× Cipta Sarana Medika Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (12.05M versus 2.87M). Which is the better fit depends on your goals.

DKHHSWID
Market Cap
163.22B608.51B
Volume
2.87M12.05M
Lot
28.67K120.51K
Turnover
182.67M1.33B
Average Price
63.71110.02
Value
182.67M1.33B
Indicative Equilibrium Price
64114
Indicative Equilibrium Volume
110.6K1.97K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
SWID
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Saraswanti Indoland Development Tbk.

PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.

Read more on SWID